Utah Medical Products, Inc. (UTMD) Financials
UTMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 131.2 million | 7.5 million |
| 2023-06-30 | 130.5 million | 8.7 million |
| 2023-03-31 | 127.8 million | 9.8 million |
UTMD Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 4.9 million | 53000 |
| 2023-06-30 | 4.6 million | 50000 |
| 2023-03-31 | 6.9 million | 50000 |
UTMD Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 4.3 million |
| 2023-09-30 | 3.9 million |
| 2023-06-30 | 4.2 million |
| 2023-03-31 | 4.2 million |
UTMD Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 88.2 million | - | 305000 |
| 2023-06-30 | 84.6 million | - | 315000 |
| 2023-03-31 | 80.9 million | - | 328000 |
UTMD Shares Outstanding
UTMD Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 186000 | 138000 | 3.3 million | - |
| 2023-06-30 | 320000 | 133000 | 3.2 million | - |
| 2023-03-31 | 43000 | 144000 | 3.3 million | - |
UTMD Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 12.5 million | 5.1 million |
| 2023-06-30 | 12.9 million | 5.1 million |
| 2023-03-31 | 4.7 million | 4.7 million |
UTMD
Price: $68.13
Dividend Yield: 0.02%
Forward Dividend Yield: 1.76%
Payout Ratio: 26.20%
Dividend Per Share: 1.20 USD
Earnings Per Share: 4.58 USD
P/E Ratio: 15.96
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 3476
Ebitda: 21.0 millionMarket Capitalization: 249.2 million
Average Dividend Frequency: 4
Years Paying Dividends: 21
DGR3: 2.31%
DGR5: 2.11%
DGR10: 1.89%